Items tagged with Drug-resistant TB
Indian civil society pushes for government use compulsory license on MDR-TB drugs (post with simple image)
Advocates appeal to the Prime Minister of India to issue a government use compulsory license for bedaquiline and delamanid to encourage generic competition.
New guide to shorter regimen for treating drug-resistant TB (post with simple image)
DR-TB STAT + TAG brief: Is Shorter Better? Understanding the Shorter Regimen For Treating Drug-Resistant Tuberculosis
WHO treatment guidelines for isoniazid-resistant TB (post with simple image)
The World Health Organization issues recommendations on management of isoniazid-resistant TB.
WHO response to STREAM Stage 1 preliminary results (post with simple image)
WHO issues a position statement on the continued use of the shorter MDR-TB regimen following an expedited review of the STREAM Stage 1 preliminary result.
Advocates call for urgent reforms of WHO TB diagnosis and treatment guidelines (post with simple image)
Advocates call on WHO leadership to ensure rapid development of clear, consolidated guidelines for the diagnosis and treatment of TB.
South Africa makes bedaquiline part of its standard recommended treatment regimen for rifampicin-resistant TB (post with simple image)
Global TB CAB welcomes introduction of safer drug for most South Africans with rifampicin-resistant TB; Other countries and the World Health Organization must now follow.
Treatment Action Group welcomes price reductions for TB medicines (post with simple image)
Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.
Advocates call on Indian Minister of Health to introduce injection-free drug-resistant TB treatment regimen (post with simple image)
Advocates request that bedaquiline become part of the standard treatment regimen for drug-resistant TB in India.
Advocates call for policies to support all-oral regimens for children with drug-resistant TB (post with simple image)
Advocates release recommendations for injectable-free regimens for children under the age of 12 years.
Activists call on Johnson & Johnson to drop the price of bedaquiline (post with simple image)
Activists ask the company to drop the price of bedaquiline in all markets to $32 a month or lower.
Page 78 of 80 · Total posts: 0←First 77 78 79 Last→